Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

32.49 +0.38 (+1.20%)

Streaming Delayed Price Updated: 12:13 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

31 32 Next >

World Markets News For Monday ↗

February 14, 2022

European markets were down over fear of Ukrainian battles.

Via Talk Markets

Nuclear Winter ↗

February 11, 2022

Mexico is raising interest rates to 6%, from 5.5%.

Via Talk Markets

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

Dampening Exuberance ↗

February 09, 2022

The bond sell-off halted today but the Fed's plans mean this will resume.

Via Talk Markets

Why Are Teva Pharmaceutical Shares Trading Higher Today? ↗

February 09, 2022

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)

Via Benzinga

The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical ↗

February 09, 2022

Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.

Via Investor's Business Daily

Earnings Scheduled For February 9, 2022 ↗

February 09, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.

Via Benzinga

Price To Earnings Ratio Insights For Teva Pharmaceutical ↗

February 07, 2022

Via Benzinga

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗

February 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Teva Pharmaceutical: Q4 Earnings Insights ↗

February 09, 2022

Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Teva Reports Fourth Quarter and Full Year 2021 Financial Results

February 09, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Markets News for Tuesday ↗

February 08, 2022

Oil stocks are up on huge gains.

Via Talk Markets

Teva, Texas Enter $225M Opioid Settlement Agreement ↗

February 07, 2022

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a

Via Benzinga

Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims

February 07, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Weakened Tech Stocks ↗

February 03, 2022

There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.

Via Talk Markets

World Markets News for Wednesday ↗

February 02, 2022

Gold and the Euro are up as the greenback loses traction.

Via Talk Markets

World Markets News for Tuesday ↗

February 01, 2022

Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.

Via Talk Markets

Research Finds COVID Pandemic Worsened Health Equity Gap

February 01, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Drug Troubles ↗

January 28, 2022

The drug sector has both good news and bad.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗

January 27, 2022

Upgrades

Via Benzinga

The Best REITs To Buy Right Now Will Pay 8.5% Yield ↗

January 25, 2022

Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -...

Via Talk Markets

7 Stocks to Buy That Are Nowhere Near Being Overvalued ↗

January 18, 2022

These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects.

Via InvestorPlace

Chopped Stocks ↗

January 18, 2022

The day's theme is sell tech and buy banks.

Via Talk Markets

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022

January 18, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

More Serious Matters ↗

January 14, 2022

Wall Street fell on new worries about inflation and a drop in retail sales levels.

Via Talk Markets

Two Curses Of The Current Year ↗

January 13, 2022

The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.

Via Talk Markets

Start Of The Week ↗

January 10, 2022

British property (real estate) stocks fell today.

Via Talk Markets

Post-Fed Thursday ↗

January 06, 2022

Companies earning in dollars but incorporated abroad and paying dividends in other currencies were big gainers today.

Via Talk Markets

Good Deed Turns Sour ↗

January 05, 2022

Kazakhstan, which supplies 40% of the uranium the world uses now, has entered a state of emergency. It is likely that uranium mining will be hit with strikes.

Via Talk Markets

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.